Prevalence of Hemoglobinopathies in Different Age Groups- A One Year Study in Tertiary Care Centre
DOI:
https://doi.org/10.21276/apalm.3733Keywords:
high-performance liquid chromatography (hplc), complete blood count (cbc), thalassemia, sickle cell disease, prevalenceAbstract
Aim and background Hemoglobinopathies such as thalassemia and sickle cell disease are among the most common genetic disorders in India, with carrier rates ranging from 3% to 17%. Each year, 9,000–10,000 new β-thalassemia cases are added, and prevalence is particularly high among certain ethnic groups, scheduled tribes, and in eastern/northeastern regions with HbE. Despite 10,000–12,000 thalassemia births annually, most affected children lack adequate care. Strengthening public awareness, carrier screening, prenatal diagnosis, and access to treatment is essential, with HPLC serving as preferred diagnostic tool. Material and method This one-year observational study at PGIMS Rohtak included all samples submitted for HPLC with suspected hemoglobinopathies. Each sample underwent complete hemogram and HPLC analysis to detect and characterize hemoglobin variants. Chromatogram findings were interpreted with CBC data to ensure diagnostic accuracy. Result Of all samples analyzed, 74.9% showed normal HPLC patterns, while 25.1% revealed abnormalities. β-thalassemia trait was the most common hemoglobinopathy (55.7%), followed by HbD Punjab heterozygous (25.8%) and HbE heterozygous (4.9%); fewer cases of β-thalassemia major, intermedia, HbE homozygous, double heterozygous HbE/β-thalassemia, and sickle cell trait were identified. Most hemoglobinopathies occurred in individuals ≤30 years, with a female predominance in several subtypes. Hematological profiles showed microcytic hypochromic anemia in thalassemia major, moderate indices in intermedia/trait, higher red cell parameters in HbE homozygous, and elevated HbF in thalassemia major. Conclusion HPLC is a rapid and reliable method for detecting hemoglobinopathies, demonstrating regional variation and distinct subtype profiles. Complementary molecular methods and genetic counselling are essential for better management and prevention.References
1. Chiabrando D, Mercurio S, Tolosano E. Heme and erythropoiesis: more than a structural role. Hematologica. 2014;99(6):973-83.
2. Garje M, Sonwane BR, Gupta S, Narkhede P. Importance of family studies with high performance liquid chromatography in hemoglobin disorders: an analysis of 37 families. Int J Pathol Clin Res. 2020;6(10):1-5.
3. Madan N, Sharma S, Sood SK, Colah R, Bhatia LH. Frequency of β-thalassemia trait and other hemoglobinopathies in northern and western India. Indian J Hum Genet. 2010;16(1):16-25.
4. Mohanty D, Colah RB, Gorakshakar AC, Patel RZ, Master DC, Mahanta J, et al. Prevalence of β-thalassemia and other hemoglobinopathies in six cities in India: a multicentre study. J Community Genet. 2013;4(1):33-42.
5. Christianson A, Howson CP, Modell B. March of Dimes: global report on birth defects, the hidden toll of dying and disabled children. New York: March of Dimes Birth Defects Foundation; 2006. p. 10-6.
6. Grow K, Vashist M, Abrol P, Sharma S, Yadav R. β-thalassemia in India: current status and the challenges ahead. Int J Pharm Pharm Sci. 2014;6(4):28-33.
7. Williams TN, Weatherall DJ. World distribution, population genetics, and health burden of the hemoglobinopathies. Cold Spring Harb Perspect Med. 2012 Sep;2(9):a011692.
8. -George E, Jamal AR, Khalid F, Osman KA. High performance liquid chromatography as a screening tool for classical β-thalassemia trait in Malaysia. Malays J Med Sci. 2001;8(2):40-6.
9. Mondal SK, Mandal S. Prevalence of thalassemia and hemoglobinopathy in eastern India: a 10-year high-performance liquid chromatography study of 119,336 cases. Asian J Transfus Sci. 2016;10(1):105-10.
10. Kavitha A, Kavita V, Mukilarasi. Incidence of hemoglobinopathies in South Indian population: a 4-year study. Arch Pathol Lab Med. 2023;10(5):47-52.
11. Zia TUH, Ahmed A, Ilyas M, Siyar H, Bahadar H. Spectrum of hemoglobinopathies in tertiary care hospitals of Rawalpindi and Islamabad. Pak Biomed J. 2024;7(3):7-10.
12. Pradnya P, Abhijit P. Hemoglobin variant study by HPLC method at a tertiary care centre. Int J Health Sci Res. 2023;6(11):2841-8.
Downloads
Published
Issue
Section
License
Copyright (c) 2026 Sonia Chhabra, Santosh Yadav, Vaishali, Monika Gupta, Sunita Singh
This work is licensed under a Creative Commons Attribution 4.0 International License.
Authors who publish with this journal agree to the following terms:
- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access at http://opcit.eprints.org/oacitation-biblio.html).
How to Cite
